Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Dec;104(4):995–999. doi: 10.1111/j.1476-5381.1991.tb12539.x

Protective action of clonidine against the arrhythmogenic and lethal effects of ouabain in guinea-pigs.

G P Thomas 1, P M Stephen 1
PMCID: PMC1908856  PMID: 1687372

Abstract

1. Clonidine (1.25, 2.5 and 5.0 micrograms kg-1) was studied for its effect on the cardiac arrhythmias and lethality induced by slow intravenous infusion of ouabain in guinea-pigs. 2. Clonidine produced significant delays in the onset of the arrhythmic stages and lethality. However, clonidine did not offer any such protection in reserpinised guinea-pigs, whereas its effects were unaltered in atropinized guinea-pigs. 3. Idazoxan (100 micrograms kg-1, i.v.) abolished the antiarrhythmic effect of clonidine whereas corynanthine (1 mg kg-1, i.v.) had no such effect. 4. Clonidine inhibited the rate of the ouabain-induced rise in blood pressure and the peak pressor response. 5. In isolated paced left atria of the guinea-pig, clonidine (3.75 x 10(-4) M) did not offer any protection against rapid and/or irregular extrasystolic contractions induced by ouabain. 6. It is concluded that the antiarrhythmic effect of clonidine is due to its effects on the indirect neural components of digitalis toxicity mediated by the stimulation of alpha 2-adrenoceptors, without any direct antiarrhythmic effect on the myocardium.

Full text

PDF
996

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Damluji S., Ross G., Touzel R., Perrett D., White A., Besser G. M. Modulation of the actions of tyrosine by alpha 2-adrenoceptor blockade. Br J Pharmacol. 1988 Oct;95(2):405–412. doi: 10.1111/j.1476-5381.1988.tb11660.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bousquet P., Schwartz J. Alpha-adrenergic drugs. Pharmacological tools for the study of the central vasomotor control. Biochem Pharmacol. 1983 May 1;32(9):1459–1465. doi: 10.1016/0006-2952(83)90466-5. [DOI] [PubMed] [Google Scholar]
  3. Cavero I., Roach A. G. The effects of prazosin on the clonidine induced hypotension and bradycardia in rats and sedation in chicks [proceedings]. Br J Pharmacol. 1978 Mar;62(3):468P–469P. [PMC free article] [PubMed] [Google Scholar]
  4. Drew G. M. Effects of alpha-adrenoceptor agonists and antagonists on pre- and postsynaptically located alpha-adrenoceptors. Eur J Pharmacol. 1976 Apr;36(2):313–320. doi: 10.1016/0014-2999(76)90084-4. [DOI] [PubMed] [Google Scholar]
  5. Ferrier G. R. Digitalis arrhythmias: role of oscillatory afterpotentials. Prog Cardiovasc Dis. 1977 May-Jun;19(6):459–474. doi: 10.1016/0033-0620(77)90010-x. [DOI] [PubMed] [Google Scholar]
  6. Gillis R. A., Jolson H., Thibodeaux H., Levitt B. Antagonism of deslanoside-induced cardiotoxicity by combined nicotinic and muscarinic blockade of autonomic ganglia. J Pharmacol Exp Ther. 1975 Oct;195(1):126–132. [PubMed] [Google Scholar]
  7. Gillis R. A., Quest J. A. The role of the nervous system in the cardiovascular effects of digitalis. Pharmacol Rev. 1979 Mar;31(1):19–97. [PubMed] [Google Scholar]
  8. Hamilton T. C., Longman S. D. A comparison of the cardiovascular and sedative actions of the alpha-adrenoceptor agonists, FLA-136 and clonidine, in the rat. Br J Pharmacol. 1982 Jan;75(1):13–21. doi: 10.1111/j.1476-5381.1982.tb08753.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hernández J., Serrano J. S. Effect of different beta-blocking agents on an in vitro model of ventricular automaticity. Methods Find Exp Clin Pharmacol. 1982;4(5):307–311. [PubMed] [Google Scholar]
  10. Hoefke W., Kobinger W. Pharmakologische Wirkungen des 2-(2,6-Dichlorphenylamino)-2-imidazolin-hydrochlorids, einer neuen, antihypertensiven Substanz. Arzneimittelforschung. 1966 Aug;16(8):1038–1050. [PubMed] [Google Scholar]
  11. Kelliher G. J., Roberts J. A study of the antiarrhythmic action of certain beta-blocking agents. Am Heart J. 1974 Apr;87(4):458–467. doi: 10.1016/0002-8703(74)90171-9. [DOI] [PubMed] [Google Scholar]
  12. Kobinger Central alpha-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol. 1978;81:39–100. doi: 10.1007/BFb0034091. [DOI] [PubMed] [Google Scholar]
  13. Lechat P., Schmitt H. Interactions between the autonomic nervous system and the cardiovascular effects of ouabain in guinea-pigs. Eur J Pharmacol. 1982 Feb 19;78(1):21–32. doi: 10.1016/0014-2999(82)90368-5. [DOI] [PubMed] [Google Scholar]
  14. Levitt B., Roberts J. The capacity of different digitalis materials to induce ventricular rhythm disturbances in the reserpine-pretreated cat. J Pharmacol Exp Ther. 1967 Apr;156(1):159–165. [PubMed] [Google Scholar]
  15. Pace D. G., Gillis R. A. Neuroexcitatory effects of digoxin in the cat. J Pharmacol Exp Ther. 1976 Dec;199(3):583–600. [PubMed] [Google Scholar]
  16. Roberts J., Levitt B., Standaert F. G. Autonomic nervous system and control of cardiac rhythm. Nature. 1967 May 27;214(5091):912–913. doi: 10.1038/214912a0. [DOI] [PubMed] [Google Scholar]
  17. Saito H., Otani T., Shudo I., Tanabe T. Effect of 6-hydroxydopamine on cardiotoxicity of ouabain in guinea pigs. Jpn J Pharmacol. 1974 Dec;24(6):923–925. doi: 10.1254/jjp.24.923. [DOI] [PubMed] [Google Scholar]
  18. Saxena P. R., Bhargava K. P. The importance of a central adrenergic mechanism in the cardiovascular responses to ouabain. Eur J Pharmacol. 1975 Apr;31(2):332–346. doi: 10.1016/0014-2999(75)90057-6. [DOI] [PubMed] [Google Scholar]
  19. Smith T. W., Antman E. M., Friedman P. L., Blatt C. M., Marsh J. D. Digitalis glycosides: mechanisms and manifestations of toxicity. Part III. Prog Cardiovasc Dis. 1984 Jul-Aug;27(1):21–56. doi: 10.1016/0033-0620(84)90018-5. [DOI] [PubMed] [Google Scholar]
  20. Thomas G. P., Tripathi R. M. Effects of alpha-adrenoceptor agonists and antagonists on ouabain-induced arrhythmias and cardiac arrest in guinea-pig. Br J Pharmacol. 1986 Oct;89(2):385–388. doi: 10.1111/j.1476-5381.1986.tb10271.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Timmermans P. B., Lam E., Van Zwieten P. A. The interaction between prazosin and clonidine at alpha-adrenoceptors in rats and cats. Eur J Pharmacol. 1979 Apr 1;55(1):57–66. doi: 10.1016/0014-2999(79)90147-x. [DOI] [PubMed] [Google Scholar]
  22. Timmermans P. B., Van Zwieten P. A. Hypotensive and bradycardic activities of clonidine and related imidazolidines; structure-activity relationship. Arch Int Pharmacodyn Ther. 1977 Aug;228(2):237–250. [PubMed] [Google Scholar]
  23. Trzeciakowski J. P. Protective action of cimetidine against ouabain-induced pressor effects, arrhythmias, and lethality in guinea pigs. J Cardiovasc Pharmacol. 1985 Jul-Aug;7(4):622–629. doi: 10.1097/00005344-198507000-00002. [DOI] [PubMed] [Google Scholar]
  24. Weitzell R., Tanaka T., Starke K. Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn Schmiedebergs Arch Pharmacol. 1979 Aug;308(2):127–136. doi: 10.1007/BF00499054. [DOI] [PubMed] [Google Scholar]
  25. Yamada Y., Nakazato Y., Ohga A. Ouabain distinguishes between nicotinic and muscarinic receptor-mediated catecholamine secretions in perfused adrenal glands of cat. Br J Pharmacol. 1989 Feb;96(2):470–479. doi: 10.1111/j.1476-5381.1989.tb11840.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. van Zwieten P. A., Timmermans P. B. Cardiovascular alpha 2-receptors. J Mol Cell Cardiol. 1983 Nov;15(11):717–733. doi: 10.1016/0022-2828(83)90332-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES